Innate immunity induced by fungal β-glucans via dectin-1 signaling pathway

International Journal of Medicinal Mushrooms

Volumn 16, Issue 1, 2014, Pages 1-16

  Lee, Dong Hee ^a   Kim, Ha Won ^a  

^a University of Seoul   (South Korea)

Author keywords

2 stage model; Anticancer; Complement receptor 3; Dectin 1; Innate immunity; Medicinal mushrooms; PAMP; PRR; Toll like receptor; glucan; glucan intestinal absorption

Indexed keywords

CASPASE 3; INONOTUS OBLIQUUS EXTRACT; PROTEIN BCL 2; ANTINEOPLASTIC AGENT; BETA GLUCAN; DECTIN 1; LECTIN; PLANT EXTRACT;

ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; CANCER INHIBITION; CELL CYCLE; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MTT ASSAY; NERVOUS SYSTEM TUMOR; NEUROGLIOCYTOMA; PROTEIN EXPRESSION; REVIEW; UPREGULATION; WESTERN BLOTTING; AGARICALES; ANIMAL; CHEMISTRY; DRUG EFFECTS; GENETICS; IMMUNOLOGY; INNATE IMMUNITY; MEDICINAL PLANT; METABOLISM; NEOPLASMS; SIGNAL TRANSDUCTION;

AGARICALES; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BETA-GLUCANS; HUMANS; IMMUNITY, INNATE; LECTINS, C-TYPE; NEOPLASMS; PLANT EXTRACTS; PLANTS, MEDICINAL; SIGNAL TRANSDUCTION;

EID: 84895793772     PISSN: 15219437     EISSN: 19404344     Source Type: Journal    
DOI: 10.1615/IntJMedMushr.v16.i1.10     Document Type: Review

References (95)

1. Reid DM, Gow NA, Brown GD. Pattern recognition: recent insights from Dectin-1. Curr Opin Immunol. 2009;21:30-37.
2. Gee K, Angel JB, Mishra S, Blahoianu MA, Kumar A. IL-10 regulation by HIV-Tat in primary human mono- cytic cells: involvement of calmodulin/calmodulin-dependent protein kinase-activated p38 MAPK and Sp-1 and CREB-1 transcription factors. J Immunol. 2007;178:798-807.
3. Monaghan J, Zipfel C. Plant pattern recognition receptor complexes at the plasma membrane. Curr Opin Plant Biol. 2012;15:349-357.
4. Sun L, Zhao Y. The biological role of Dectin-1 in immune response. Int Rev Immunol. 2007;26:349-364.
5. Takeuchi O, Akira S. Pattern recognition receptors and infammation. Cell. 2010;140:805-20.
6. Brown GD. Dectin-1: a signalling non-TLR pattern-recognition receptor. Nat Rev Immunol. 2006;6:33-43.
7. Gordon S, Martinez FO. Alternative activation of macrophages: mechanism and functions. Immunity. 2010;32:593-604.
8. Gay NJ, Keith FJ. Drosophila Toll and IL-1 receptor. Nature. 1991;351:355-56.
9. Kumar H, Kawai T, Akira S. Toll-like receptors and innate immunity. Biochem Biophys Res Commun. 2009;388:621-625.
10. Chan GCF, Chan WK, Sze DMY. The effects of β-glucan on human immune and cancer cells. J Hematol Oncol. 2009;2:25.
11. Brown GD, Gordon S. Fungal β-glucans and mammalian immunity. Immunity. 2003;19:311-335.
12. Pichlmair A, Reise Sousa C. Innate recognition of viruses. Immunity. 2007;27:370-383.
13. Saito T, Hirai R, Loo YM, Owen D, Johnson CL, Sinha SC, Akira S, Fujita T, Gale M Jr. Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2. Proc Natl Acad Sci U S A. 2007;104:582-587.
14. Takeuchi O, Akira S. Innate immunity to virus infection. Immunol Rev. 2009;227:75-86.
15. Liu F, Gu J. Retinoic acid inducible gene-I, more than a virus sensor. Protein Cell. 2011;2:351-357.
16. Takahasi K, Kumeta H, Tsuduki N, Narita R, Shigemoto T, Hirai R, Yoneyama M, Horiuchi M, Ogura K, Fujita T, Inagaki F. Solution structures of cytosolic RNA sensor MDA5 and LGP2 C-terminal domains: identifcation of the RNA recognition loop in RIG-I-like receptors. J Biol Chem. 2009;284:17465-17474.
17. Kumagai Y, Akira S. Identifcation and functions of pattern-recognition receptors. J Allergy Clin Immunol. 2010;125:985-92.
18. Yoneyama M, Kikuchi M, Matsumoto K, Imaizumi T, Miyagishi M, Taira K, Foy E, Loo YM, Gale M Jr, Aki-ra S, Yonehara S, Kato A, Fujita T. Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J Immunol. 2005;175:2851-58.
19. Jung K, Ha Y, Ha SK, Han DU, Kim DW, Moon WK, Chae C. Antiviral effect of Saccharomyces cerevisiae β-glucan to swine infuenza virus by increased production of interferon-gamma and nitric oxide. J Vet Med B Infect Dis Vet Public Health. 2004;51:72-76.
20. Xiao Z, Trincado CA, Murtaugh MP. β-glucan enhancement of T cell IFNg response in swine. Vet Immunol Im-munopathol. 2004;102:315-20.
21. Murphy EA, Davis JM, Carmichael MD, Mayer EP, Ghaffar A. Benefts of oat β-glucan and sucrose feedings on infection and macrophage antiviral resistance following exercise stress. Am J Physiol Regul Integr Comp Physiol. 2009;297:R1188-94.
22. Wang SC, Bligh SW, Zhu CL, Shi SS, Wang ZT, Hu ZB, Crowder J, Branford-White C, Vella C. Sulfated β-glucan derived from oat bran with potent anti-HIV activity. J Agric Food Chem. 2008;56:2624-29.
23. Rosentul DC, Plantinga TS, Papadopoulos A, Joosten LA, Antoniadou A, Venselaar H, Kullberg BJ, Van Der Meer JW, Giamarellos-Bourboulis EJ, Netea MG. Variation in genes of β-glucan recognition pathway and susceptibility to opportunistic infections in HIV-positive patients. Immunol Invest. 2011;40:735-50.
24. Muramatsu D, Iwai A, Aoki S, Uchiyama H, Kawata K, Nakayama Y, Nikawa Y, Kusano K, Okabe M, Miyazaki T. β-glucan derived from Aureobasidium pullulans is effective for the prevention of infuenza in mice. PLoS One. 2012;7:e41399.
25. Abdul-Sater AA, Saïd-Sadier N, Lam VM, Singh B, Pettengill MA, Soares F, Tattoli I, Lipinski S, Girardin SE, Rosenstiel P, Ojcius DM. Enhancement of reactive oxygen species production and chlamydial infection by the mitochondrial Nod-like family member NLRX1. J Biol Chem. 2010;285:41637-45.
26. Xia X, Cui J, Wang HY, Zhu L, Matsueda S, Wang Q, Yang X, Hong J, Songyang Z, Chen ZJ, Wang RF. NLRX1 negatively regulates TLR-induced NF-κB signaling by targeting TRAF6 and IKK. Immunity. 2011;34:843-53.
27. Kankkunen P, Teirilä L, Rintahaka J, Alenius H, Wolff H, Matikainen S. (1,3)-β-glucans activate both Dectin-1 and NLRP3 infammasome in human macrophages. J Immunol. 2010;184:6335-42.
28. Kumar H, Kumagai Y, Tsuchida T, Koenig PA, Satoh T, Guo Z, Jang MH, Saitoh T, Akira S, Kawai T. Involvement of the NLRP3 infammasome in innate and humoral adaptive immune responses to fungal β-glucan. J Immunol. 2009;183:8061-67.
29. Figdor CG, van Kooyk Y, Adema GJ. C-type lectin receptors on dendritic cells and Langerhans cells. Nat Rev Immunol. 2002;2:77-84.
30. Lahoud MH, Ahmet F, Zhang JG, Meuter S, Policheni AN, Kitsoulis S, Lee CN, O'Keeffe M, Sullivan LC, Brooks AG, Berry R, Rossjohn J, Mintern JD, Vega-Ramos J, Villadangos JA, Nicola NA, Nussenzweig MC, Stacey KJ, Shortman K, Heath WR, Caminschi I. DEC-205 is a cell surface receptor for CpG oligonucleotides. Proc Natl Acad Sci U S A. 2012;109:16270-75.
31. Porcaro I, Vidal M, Jouvert S, Stahl PD, Giaimis J. Man- nose receptor contribution to Candida albicans phagocytosis by murine E-clone J774 macrophages. J Leukoc Biol. 2003;74:206-15.
32. Li YJ, Petrofsky M, Bermudez LE. Mycobacterium tuberculosis uptake by recipient host macrophages is infu-enced by environmental conditions in the granuloma of the infectious individual and is associated with impaired production of interleukin-12 and tumor necrosis factor alpha. Infect Immun. 2002;70:6223-30.
33. Ezekowitz RAB, Williams DJ, Koziel H, Armstrong MYK, Warner A, Richards FF, Rose RM. Uptake of Pneumocystis carinii mediated by the macrophage man-nose receptor. Nature. 1991;351:155-58.
34. Athamna A, Ofek I, Keisari Y, Markowitz S, Dutton GG, Sharon N. Lectinophagocytosis of encapsulated Klebsi-ella pneumoniae mediated by surface lectins of guinea pig alveolar macrophages and human monocyte-derived macrophages. Infect Immun. 1991;59:1673-82.
35. Nguyen DG, Hildreth JE. Involvement of macrophage mannose receptor in the binding and transmission of HIV by macrophages. Eur J Immunol. 2003;33:483-93.
36. Miller JL, de Wet BJ, Martinez-Pomares L, Radcliffe CM, Dwek RA, Rudd PM, Gordon S. The mannose receptor mediates dengue virus infection of macrophages. PLoS Pathog. 2008;4:e17.
37. Op den Brouw ML, Binda RS, Geijtenbeek TB, Jans-sen HL, Woltman AM. The mannose receptor acts as hepatitis B virus surface antigen receptor mediating interaction with intrahepatic dendritic cells. Virology. 2009;393(1):84-90.
38. Tate MD, Brooks AG, Reading PC. Specifc sites of N-linked glycosylation on the hemagglutinin of H1N1 subtype infuenza A virus determine sensitivity to inhibitors of the innate immune system and virulence in mice. J Immunol. 2011;187:1884-94.
39. Mora-Montes HM, Ponce-Noyola P, Villagómez-Cas-tro JC, Gow NA, Flores-Carreón A, López-Romero E. Protein glycosylation in Candida. Future Microbiol. 2009;4:1167-83.
40. Perez-Garcia LA, Diaz-Jimenez DF, Lopez-Esparza A, Mora HM. Role of cell wall polysaccharides during recognition of Candida albicans by the innate immune system. J Glycobiol. 2011;1:102.
41. Cambi A, Netea MG, Mora-Montes HM, Gow NA, Hato SV, Lowman DW, Kullberg BJ, Torensma R, Williams DL, Figdor CG. Dendritic cell interaction with Candida albicans critically depends on N-linked mannan. J Biol Chem. 2008;283:20590-99.
42. Jouault T, Abed-El Behi M, Martínez-Esparza M, Breuilh L, Trinel PA, Chamaillard M, Trottein F, Poulain D. Specifc recognition of Candida albicans by macro-phages requires galectin-3 to discriminate Saccharomy-ces cerevisiae and needs association with TLR2 for signaling. J Immunol. 2006;177:4679-87.
43. Wells CA, Salvage-Jones JA, Li X, Hitchens K, Butcher S, Murray RZ, Beckhouse AG, Lo YL, Manzanero S, Cobbold C, Schroder K, Ma B, Orr S, Stewart L, Lebus D, Sobieszczuk P, Hume DA, Stow J, Blanchard H, Ashman RB. The macrophage-inducible C-type lectin, Mincle, is an essential component of the innate immune response to Candida albicans. J Immunol. 2008;180:7404-13.
44. Saijo S, Ikeda S, Yamabe K, Kakuta S, Ishigame H, Akit-su A, Fujikado N, Kusaka T, Kubo S, Chung SH, Komat-su R, Miura N, Adachi Y, Ohno N, Shibuya K, Yamamoto N, Kawakami K, Yamasaki S, Saito T, Akira S, Iwakura Y. Dectin-2 recognition of α-mannans and induction of Th17 cell differentiation is essential for host defense against Candida albicans. Immunity. 2010;32:681-91.
45. Plato A, Willment JA, Brown GD. C-type lectin-like receptors of the Dectin-1 cluster: ligands and signaling pathways. Int Rev Immunol. 2013;32:134-56.
46. Matsumoto M, Tanaka T, Kaisho T, Sanjo H, Copeland NG, Gilbert DJ, Jenkins NA, Akira S. A novel LPS-in-ducible C-type lectin is a transcriptional target of NF-IL6 in macrophages. J Immunol. 1999;163:5039-48.
47. Ichioka M, Suganami T, Tsuda N, Shirakawa I, Hirata Y, Satoh-Asahara N, Shimoda Y, Tanaka M, Kim-Saijo M, Miyamoto Y, Kamei Y, Sata M, Ogawa Y. Increased expression of macrophage-inducible C-type lectin in adipose tissue of obese mice and humans. Diabetes. 2011;60:819-26.
48. Yamasaki S, Matsumoto M, Takeuchi O, Matsuzawa T, Ishikawa E, Sakuma M, Tateno H, Uno J, Hirabayashi J, Mikami Y, Takeda K, Akira S, Saito T. C-type lectin Min-cle is an activating receptor for pathogenic fungus, Mal-assezia. Proc Natl Acad Sci U S A. 2009;106:1897-902.
49. Brown GD. Sensing necrosis with Mincle. Nat Immunol. 2008;9:1099-100.
50. Geijtenbeek TB, Torensma R, van Vliet SJ, van Duijn-hoven GC, Adema GJ, van Kooyk Y, Figdor CG. Iden-tifcation of DC-SIGN, a novel dendritic cell-specifc ICAM-3 receptor that supports primary immune responses. Cell. 2000;100:575-85.
51. den Dunnen J, Gringhuis SI, Geijtenbeek TB. Innate signaling by the C-type lectin DC-SIGN dictates immune responses. Cancer Immunol Immunother. 2009;58:1149-57.
52. Sancho D, Mourão-Sá D, Joffre OP, Schulz O, Rogers NC, Pennington DJ, Carlyle JR, Reise Sousa C. Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin. J Clin Invest. 2008;118:2098-110.
53. Brown GD. Immunology: Actin' dangerously. Nature. 2012;485:589-90.
54. Murray PJ. Understanding and exploiting the endogenous interleukin-10/STAT3-mediated anti-infammatory response. Curr Opin Pharmacol. 2006;6:379-86.
55. Ouyang W, Rutz S, Crellin NK, Valdez PA, Hymowitz SG. Regulation and functions of the IL-10 family of cy-tokines in infammation and disease. Annu Rev Immunol. 2011;29:71-109.
56. Ferwerda G, Meyer-Wentrup F, Kullberg BJ, Netea MG, Adema GJ. Dectin-1 synergizes with TLR2 and TLR4 for cytokine production in human primary monocytes and macrophages. Cell Microbiol. 2008;10:2058-66.
57. Gantner BN, Simmons RM, Underhill DM. Dectin-1 mediates macrophage recognition of Candida albicans yeast but not flaments. EMBO J. 2005;24:1277-86.
58. Alvarez Y, Municio C, Alonso S, Sánchez Crespo M, Fernández N. The induction of IL-10 by zymosan in DCs depends on CREB activation by the coactivators CREB-binding protein and TORC2 and autocrine PGE2. J Immunol. 2009;183:1471-79.
59. Ruland J. CARD9 signaling in the innate immune response. Ann N Y Acad Sci. 2008;1143:35-44.
60. Skaug B, Jiang X, Chen ZJ. The role of ubiquitin in NF-kB regulatory pathways. Annu Rev Biochem. 2009;78:769-96.
61. Kato Y, Adachi Y, Ohno N. Contribution of N-linked oli-gosaccharides to the expression and functions of β-glucan receptor, Dectin-1. Biol Pharm Bull. 2006;29:1580-86.
62. Willment JA, Brown GD. C-type lectin receptors in anti-fungal immunity. Trends Microbiol. 2008;16:27-32.
63. Batbayar S, Lee DH, Kim HW. Immunomodulation of fungal ß-glucan in host defense Signaling by Dectin-1. Biomol Ther. 2012;20:433-45.
64. Wasser SP. Current fndings, future trends, and unsolved problems in studies of medicinal mushrooms. Appl Mi-crobiol Biotechnol. 2011;89:1323-32.
65. Kim HW, Shim MJ, Choi EC, Kim BK. Inhibition of cytopathic effect of human immunodefciency virus-1 by water-soluble extract of Ganoderma lucidum. Arch Pharm Res. 1997;20:425-31.
66. Newsome CT, Flores E, Ayala A, Gregory S, Reich-ner JS. Improved antimicrobial host defense in mice following poly-(1,6)-β-D-glucopyranosyl-(1,3)-β-D-glucopyranose glucan treatment by a gender-dependent immune mechanism. Clin Vaccine Immunol. 2011;18:2043-49.
67. Toklu HZ, Sehirli AO, Velioglu-Ogünç A, Cetinel S, Sener G. Acetaminophen-induced toxicity is prevented by β-D-glucan treatment in mice. Eur J Pharmacol. 2006;543:133-40.
68. Guerra Dore CM, Azevedo TC, de Souza MC, Rego LA, de Dantas JC, Silva FR, Rocha HA, Baseia IG, Leite EL. Antiinfammatory, antioxidant and cytotoxic actions of β-glucan-rich extract from Geastrum saccatum mushroom. Int Immunopharmacol. 2007;7:1160-69.
69. Xiao C, Wu QP, Cai W, Tan JB, Yang XB, Zhang JM. Hypoglycemic effects of Ganoderma lucidum poly-saccharides in type 2 diabetic mice. Arch Pharm Res. 2012;35:1793-801.
70. Cheung PCK. The hypocholesterolemic effect of two edible mushrooms: Auricularia auricula (tree-ear) and Tremella fuciformis (white jelly-leaf) in hypercholester-olemic rats. Nutr Res. 1996;16:1721-25.
71. Yadomae T. Structure and biological activities of fungal β-1,3-glucans. Yakugaku Zasshi. 2000;120:413-31.
72. Rice PJ, Adams EL, Ozment-Skelton T, Gonzalez AJ, Goldman MP, Lockhart BE, Barker LA, Breuel KF, Deponti WK, Kalbfeisch JH, Ensley HE, Brown GD, Gordon S, Williams DL. Oral delivery and gastrointestinal absorption of soluble glucans stimulate increased resistance to infectious challenge. J Pharmacol Exp Ther. 2005;314:1079-86.
73. Hashimoto K, Suzuki I, Yadomae T. Oral administration of SSG, a β-glucan obtained from Sclerotinia sclerotio-rum, affects the function of Peyer's patch cells. Int J Im-munopharmacol. 1991;13:437-42.
74. Casteleyn C, Van den Broeck W, Gebert A, Tambuyzer BR, Van Cruchten S, Van Ginneken C. M cell specifc markers in man and domestic animals: valuable tools in vaccine development. Comp Immunol Microbiol Infect Dis. 2013;36:353-64.
75. Garrett WS, Gordon JI, Glimcher LH. Homeostasis and infammation in the intestine. Cell. 2010;140:859-70.
76. Czop JK, Austen KF. A β-glucan inhibitable receptor on human monocytes: its identity with the phagocytic receptor for particulate activators of the alternative complement pathway. J Immunol. 1985;134:2588-93.
77. Ross GD, Cain JA, Lachmann PJ. Membrane complement receptor type three (CR3) has lectin-like properties analogous to bovine conglutinin as functions as a receptor for zymosan and rabbit erythrocytes as well as a receptor for iC3b. J Immunol. 1985;134:3307-3315.
78. Thornton BP, Vetvicka V, Pitman M, Goldman RC, Ross GD. Analysis of the sugar specifcity and molecular location of the β-glucan-binding lectin site of complement receptor type 3 (CD11b/CD18). J Immunol. 1996;156:1235-1246.
79. van Bruggen R, Drewniak A, Jansen M, van Houdt M, Roos D, Chapel H, Verhoeven AJ, Kuijpers TW. Complement receptor 3, not Dectin-1, is the major receptor on human neutrophils for β-glucan-bearing particles. Mol Immunol. 2009;47:575-81.
80. Hong F, Yan J, Baran JT, Allendorf DJ, Hansen RD, Os-troff GR, Xing PX, Cheung NK, Ross GD. Mechanism by which orally administered β-1,3-glucans enhance the tumoricidal activity of antitumor monoclonal antibodies in murine tumor models. J Immunol. 2004;173:797-806.
81. Zhang M, Cui SW, Cheung PCK, Wang Q. Antitumor polysaccharides from mushrooms: a review on their isolation process, structural characteristics and antitumor activity. Trends Food Sci Technol. 2007;18:4-19.
82. Adachi Y, Okazaki M, Ohno N, Yadomae T. Enhancement of cytokine production by macrophages stimulated with (1→3)-β-D-glucan, grifolan (GRN), isolated from Grifola frondosa. Biol Pharm Bull. 1994;17:1554-60.
83. Park SK, Kim GY, Lim JY, Kwak JY, Bae YS, Lee JD, Oh YH, Ahn SC, Park YM. Acidic polysaccharides isolated from Phellinus linteus induce phenotypic and functional maturation of murine dendritic cells. Biochem Biophys Res Commun. 2003;312:449-58.
84. Shao BM, Dai H, Xu W, Lin ZB, Gao XM. Immune receptors for polysaccharides from Ganoderma lucidum. Biochem Biophys Res Commun. 2004;323:133-41.
85. Lin JY, Chen JS, Chen PC, Chung MH, Liu CY, Miaw SC, Wang LF. Concurrent exposure to a dectin-1 agonist suppresses the Th2 response to epicutaneously introduced antigen in mice. J Biomed Sci. 2013;20:1.
86. Baran J, Allendorf DJ, Hong F, Ross GD. Oral β-glucan adjuvant therapy converts nonprotective Th2 response to protective Th1 cell-mediated immune response in mammary tumor-bearing mice. Folia Histochem Cytobiol. 2007;45:107-14.
87. Li B, Allendorf DJ, Hansen R, Marroquin J, Ding C, Cramer DE, Yan J. Yeast β-glucan amplifes phagocyte killing of iC3b-opsonized tumor cells via complement receptor 3-Syk-phosphatidylinositol 3-kinase pathway. J Immunol. 2006;177:1661-69.
88. Palma AS, Feizi T, Zhang Y, Stoll MS, Lawson AM, Díaz-Rodríguez E, Campanero-Rhodes MA, Costa J, Gordon S, Brown GD, Chai W. Ligands for the β-glucan receptor, Dectin-1, assigned using "designer" microarrays of oligo-saccharide probes (neoglycolipids) generated from glucan polysaccharides. J Biol Chem. 2006;281:5771-79.
89. Slack EC, Robinson MJ, Hernanz-Falcón P, Brown GD, Williams DL, Schweighoffer E, Tybulewicz VL, Reis e Sousa C. Syk-dependent ERK activation regulates IL-2 and IL-10 production by DC stimulated with zymosan. Eur J Immunol. 2007;37:1600-1612.
90. Fleming BD, Mosser DM. Regulatory macrophages: setting the threshold for therapy. Eur J Immunol. 2011;41:2498-2502.
91. Bae SH, Kim BR, Kang BJ, Tsutsui N, Okutsu T, Shinji J, Jang IK, Han CH, Wilder MN. Molecular cloning of prophenoloxidase and the effects of dietary β-glucan and rutin on immune response in hemocytes of the feshy shrimp, Fenneropenaeus chinensis. Fish Shellfsh Immunol. 2012;33:597-604.
92. Mócsai A, Ruland J, Tybulewicz VL. The SYK tyrosine kinase: a crucial player in diverse biological functions. Nat Rev Immunol. 2010;10:387-402.
93. Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol. 2008;8:958-969.
94. Vetvicka V, Vetvickova J. β(1-3)-D-glucan affects adipo-genesis, wound healing and infammation. Orient Pharm Exp Med. 2011;11(3):169-175.
95. Yang HI, Kim WS, Kim DH, Kang JS. Histopatho-logical evaluation of heart toxicity of a novel selective PPAR-γ agonists CKD-501 in db/db Mice. Biomol Ther. 2013;21(1):84-88.